Merck (MRK) Tax Provisions (2009 - 2026)

Merck has disclosed Tax Provisions across 18 years of filings, most recently posting $709.0 million for Q1 2026.

• In Q1 2026, Tax Provisions fell 13.33% year-over-year to $709.0 million; the TTM figure through Mar 2026 stood at $2.7 billion (down 0.81% YoY), while the FY2025 annual figure was $2.8 billion, changed 0.04% from the prior year.
• Tax Provisions climbed to $709.0 million in Q1 2026, from $458.0 million in the prior quarter.
• Over the last five years, Tax Provisions for MRK reached as high as $958.0 million in Q3 2025 and fell as low as -$820.0 million in Q4 2023.
• The 5-year median for Tax Provisions is $571.0 million (2025), against an average of $573.3 million.
• Annual changes were most pronounced in 2022 — Tax Provisions surged 482.35% — and 2023, when it plunged 265.66%.
• A 5-year view of Tax Provisions shows it stood at $495.0 million in 2022, then sank by 265.66% to -$820.0 million in 2023, then surged by 151.95% to $426.0 million in 2024, then climbed by 7.51% to $458.0 million in 2025, then soared by 54.8% to $709.0 million in 2026.
• According to Business Quant data, Tax Provisions over the past three periods registered $709.0 million, $458.0 million, and $958.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.